A

Adaptive Biotechnologies Corp
D

ADPT

8.01000
USD
0.54
(7.23%)
مغلق
حجم التداول
143,822
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
1,182,111,683
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ILMN
    ILMN
    -1.005
    (-0.71%)
    140.300 USD
    M
    MTD
    -2.43
    (-0.18%)
    1,324.02 USD
    M
    MYGN
    -0.300
    (-2.39%)
    12.270 USD
    O
    OPK
    -0.02500
    (-1.67%)
    1.47500 USD
    P
    PODD
    2.66
    (0.96%)
    278.79 USD
    TMO
    TMO
    1.41
    (0.25%)
    574.31 USD
    T
    TNDM
    -0.370
    (-1.05%)
    35.000 USD
    V
    VEEV
    5.920
    (2.65%)
    229.110 USD
    المزيد
الأخبار
المقالات

العنوان: Adaptive Biotechnologies Corp

القطاع: Healthcare
الصناعة: Biotechnology
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product,clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is alsoavailable as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).